Clinical trial
Humatrope Treatment to Final Height in Turner's Syndrome
NCT00191113 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Humatrope Treatment to Final Height in Turner's Syndrome
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 1989
- Completion date
- December 31, 2007
- Enrollment
- 154 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.